Cabozanib 60mg tablet

8,849.00

42% Off
Close
Price Summary
  • 15,300.00
  • 8,849.00
  • 42%
  • 8,849.00
  • Overall you save 6,451.00 (42%) on this product
In Stock
Highlights:

Buy Cabozanib 60mg Tablet Only @10999

Substitutes for Cabozanib 60mg tablet

Cabotres 60mg tablet

Compare
Description

Last Updated on May 26, 2024 by admin

Introduction to Cabozanib 60mg Tablet

Cabozanib 60mg tablets are a targeted therapy medication used primarily in the treatment of certain types of cancer. These tablets contain Cabozanib 60mg, a tyrosine kinase inhibitor, which works by blocking the action of enzymes involved in the growth and spread of cancer cells. The chemical composition of Cabozanib 60mg includes an active ingredient specifically designed to interfere with the pathways that facilitate tumor growth and metastasis.

Manufactured by Cipla, Inc., Cabozanib 60mg has undergone extensive research and development to ensure its efficacy and safety. Exelixis, a renowned biotechnology company, has established a strong reputation in the pharmaceutical industry for its innovative therapies aimed at treating complex diseases, including various forms of cancer.

The history of Cabozanib 60mg dates back to early research phases in the mid-2000s. Through rigorous clinical trials and studies, Cabozanib 60mg demonstrated significant potential in treating cancer, leading to its eventual approval by regulatory bodies. The U.S. Food and Drug Administration (FDA) played a crucial role in this process, granting its initial approval in 2012 for the treatment of progressive, metastatic medullary thyroid cancer. Since then, the FDA has expanded its approved uses to include treatment for patients with advanced renal cell carcinoma and hepatocellular carcinoma, reflecting the drug’s versatility and effectiveness.

The introduction of Cabozanib 60mg tablets marks a significant milestone in oncology, offering a targeted approach to cancer treatment. By inhibiting specific enzymes, Cabozanib 60mg disrupts the cancer cells’ ability to grow and spread, providing a promising option for patients battling these aggressive diseases. As research continues, Cabozanib 60mg remains an essential component of the evolving landscape of cancer therapeutics, underscoring the importance of ongoing innovation in the fight against cancer.

Uses of Cabozanib 60mg Tablet

Medical Uses and Indications

Cabozanib 60mg tablets are primarily utilized in the treatment of various types of cancers, most notably renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). These conditions represent significant health challenges, and Cabozanib 60mg offers a targeted approach to manage them. The effectiveness of Cabozanib 60mg in these contexts has been supported by extensive clinical trials and ongoing research, making it a crucial component of modern oncology treatment regimens.

Renal cell carcinoma is the most common type of kidney cancer in adults. Cabozanib 60mg is often prescribed when the cancer has metastasized, meaning it has spread to other parts of the body. In these cases, Cabozanib 60mg works by inhibiting the activity of certain proteins known as tyrosine kinases. These proteins are involved in the signaling pathways that promote tumor growth and angiogenesis – the process by which new blood vessels form to supply nutrients to the tumor. By blocking these pathways, Cabozanib 60mg effectively reduces the tumor’s ability to grow and spread.

Similarly, hepatocellular carcinoma, the most prevalent form of liver cancer, can also be managed with Cabozanib 60mg. This medication is particularly beneficial for patients who have previously been treated with other therapies but have not achieved satisfactory outcomes. In hepatocellular carcinoma, Cabozanib 60mg targets multiple tyrosine kinases, including MET, AXL, and VEGF receptors, all of which play a critical role in tumor cell proliferation and survival. The inhibition of these pathways results in decreased tumor cell viability and a reduction in tumor-related symptoms.

Beyond these primary indications, Cabozanib 60mg is being investigated for its potential efficacy in treating other malignancies, including thyroid cancer and certain types of lung cancer. Researchers are continually exploring its utility in various oncologic settings, given its robust mechanism of action at the cellular level. By hindering key processes that are essential for cancer cell growth, Cabozanib 60mg represents a promising option for patients battling these aggressive diseases.

More Information about Cabozanib 60mg Tablet

  • Keep out of sight and reach of pets and children
  • Store protected from light at a temperature not exceeding 30°C.

How to consume Cabozanib 60mg Tablet

Take Cabozanib 60mg as advised by your physician. Usually, this medicine will be given once a day. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking this medicine if your doctor advises you to stop.

Dosage and Administration

When administering Cabozanib 60mg tablets, it is crucial to adhere to the prescribed dosage guidelines to ensure optimal efficacy and safety. The dosage of Cabozanib 60mg may vary depending on the specific condition being treated, as well as individual patient factors such as age, weight, and overall health. Typically, the recommended starting dose for an adult is 60 mg once daily. However, adjustments may be necessary based on the patient’s tolerance and any adverse reactions experienced. For instance, patients with renal or hepatic impairments may require a lower starting dose.

Cabozanib 60mg tablets should be taken on an empty stomach, either one hour before or two hours after a meal. This helps to maximize the absorption and effectiveness of the medication. It is important to swallow the tablets whole with water and not to crush, chew, or split them, as this can affect the drug’s efficacy.

In the event of a missed dose, patients should take the missed dose as soon as they remember, unless it is within 12 hours of the next scheduled dose. In such cases, the missed dose should be skipped, and the patient should resume their regular dosing schedule. It is advised not to double up on doses to make up for a missed one, as this can increase the risk of side effects.

If an overdose of Cabozanib 60mg occurs, it is critical to seek medical attention immediately. Symptoms of overdose may include severe fatigue, dizziness, or unusual bleeding or bruising. Healthcare providers will provide appropriate interventions to manage the overdose and mitigate any adverse effects.

Adhering to these dosage and administration guidelines can significantly impact the effectiveness and safety of Cabozanib 60mg treatment. Patients should closely follow their healthcare provider’s instructions and report any concerns or side effects experienced during the course of treatment.

Side Effects of Cabozanib 60mg Tablet

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Serious

  • Gastrointestinal perforation
  • Severe or uncontrollable bleeding
  • Shortness of breath
  • Nonhealing wound
  • Pain in the mouth, jaw/teeth, hand, feet,
  • Loss of consciousness,
  • Drowsy
  • Swelling or sores in the mouth
  • Blood vomiting
  • Black stools
  • Blood in urine
  • Headache
  • Coughing blood

Common

  • Dehydration
  • Difficulty swallowing
  • Ringing in the ears
  • Blood clots in the veins
  • Fluctuation in the blood sugar levels
  • The lower level of albumin
  • Electrolyte imbalance
  • Increased levels of liver enzymes
  • Elevated cholesterol levels in the blood
  • Hair loss
  • Changes in hair color
  • Muscle spasm
  • Skin thickening
  • Dry skin
  • Itching
  • Protein in urine

Potential Benefits and Efficacy

Cabozanib 60mg tablets have shown considerable promise in the treatment of various forms of cancer, particularly renal cell carcinoma and medullary thyroid cancer. Clinical trials have consistently demonstrated the drug’s efficacy, marking significant improvements in patient outcomes. One of the primary benefits observed is the enhanced survival rate among patients. For instance, a pivotal study revealed that patients with advanced renal cell carcinoma who were treated with Cabozanib 60mg exhibited a median overall survival rate of 21.4 months, compared to 16.5 months for those receiving standard treatment.

Beyond overall survival rates, Cabozanib 60mg has been effective in reducing tumor size, contributing to a higher percentage of patients achieving partial or complete response. In clinical trials, approximately 46% of patients with renal cell carcinoma experienced a reduction in tumor size, underscoring the drug’s potent anti-tumor activity. This reduction is particularly important as it can lead to decreased tumor burden and potentially facilitate surgical interventions or other therapeutic approaches.

Quality of life improvements have also been a notable benefit of Cabozanib 60mg tablets. Patients undergoing treatment have reported a significant reduction in pain and other cancer-related symptoms. This enhancement in quality of life is crucial, as it allows patients to maintain a higher level of daily functioning and overall well-being during their treatment journey. Additionally, Cabozanib 60mg has shown efficacy in treating bone metastases, which are often associated with severe pain and decreased mobility. By targeting these metastatic sites, the drug contributes to better pain management and improved patient comfort.

To summarize, Cabozanib 60mg tablets offer a multi-faceted approach to cancer treatment, improving survival rates, reducing tumor size, and enhancing the quality of life for patients. The clinical evidence supports its use as a potent therapeutic option, making it a valuable addition to the oncological arsenal.

Cabozanib 60mg tablets, while effective in treating certain cancers, come with a range of side effects that patients and healthcare providers need to be aware of. Commonly reported side effects include fatigue, nausea, and diarrhea. Fatigue is often described as an overwhelming sense of tiredness that can affect daily activities and quality of life. Nausea, which can sometimes lead to vomiting, is another frequent complaint, potentially impacting nutritional intake and overall well-being. Diarrhea is also a prevalent side effect, which can lead to dehydration and electrolyte imbalances if not properly managed.

Beyond these common side effects, Cabozanib 60mg tablets carry risks of more severe complications. One of the significant concerns is liver dysfunction, which can manifest as elevated liver enzymes on blood tests. This condition requires careful monitoring as it can lead to liver damage if left unchecked. Cardiovascular issues are another serious risk associated with Cabozanib 60mg. These can include hypertension, blood clots, and in rare cases, heart failure. Patients with pre-existing cardiovascular conditions need to be particularly cautious and should undergo regular cardiovascular assessments.

The importance of regular medical check-ups cannot be overstated when managing the side effects of Cabozanib 60mg tablets. Frequent blood tests and clinical evaluations help in early detection and management of potential complications. Healthcare providers may adjust the dosage or provide supportive treatments to mitigate side effects. For instance, anti-nausea medications can be prescribed to manage nausea, while anti-diarrheal agents can help control diarrhea. Additionally, lifestyle modifications such as maintaining a well-balanced diet and staying hydrated are crucial in managing some of the common side effects.

Overall, while Cabozanib 60mg tablets offer significant benefits in cancer treatment, understanding and managing the associated side effects and risks are essential for optimizing patient outcomes. Regular medical follow-ups and proactive side effect management strategies play a crucial role in ensuring the safe and effective use of this medication.

Drug Interactions and Contraindications

When considering treatment with Cabozanib 60mg tablets, it is crucial to be aware of potential drug interactions that may affect the efficacy and safety of the medication. Cabozanib 60mg can interact with various prescription medications, over-the-counter drugs, and herbal supplements, potentially leading to diminished effectiveness or increased risk of adverse effects.

One significant drug interaction involves strong CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin. These inhibitors can increase the plasma concentration of Cabozanib 60mg, heightening the risk of toxicity. Conversely, strong CYP3A4 inducers like rifampin, phenytoin, and carbamazepine may reduce the plasma concentration of Cabozanib 60mg, decreasing its therapeutic efficacy. Therefore, it is important for healthcare providers to adjust the dosage of Cabozanib 60mg or reconsider the use of these concomitant medications.

Over-the-counter drugs can also interact with Cabozanib 60mg tablets. For instance, non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen may exacerbate the risk of gastrointestinal bleeding, a known adverse effect of Cabozanib 60mg. Patients should consult their healthcare provider before taking any over-the-counter medications while on Cabozanib 60mg therapy.

Herbal supplements, including St. John’s Wort and Echinacea, may also interact with Cabozanib 60mg. St. John’s Wort, a CYP3A4 inducer, can decrease the plasma levels of Cabozanib 60mg, thereby reducing its effectiveness. Patients should disclose all herbal supplements they are taking to their healthcare provider to avoid potential interactions.

In terms of contraindications, Cabozanib 60mg should not be used in patients with known hypersensitivity to the drug or its components. Additionally, caution is advised in patients with recent history of significant hemorrhage or those at high risk of bleeding, as Cabozanib 60mg can increase bleeding risk. Patients with severe hepatic impairment should also avoid the use of Cabozanib 60mg, as the drug’s metabolism and clearance can be significantly affected, leading to increased toxicity.

Overall, understanding potential drug interactions and contraindications is essential for optimizing the therapeutic outcomes of Cabozanib 60mg tablets and minimizing adverse effects. Patients should maintain open communication with their healthcare providers and provide a comprehensive list of all medications and supplements they are taking.

Cabozanib 60mg Tablet-Use in pediatrics:

Cabozanib 60mg TABLET is not recommended for use in children and adolescents. Consult your child’s doctor for advice.

Cabozanib 60mg Tablet-Use in geriatrics:

Cabozanib 60mg TABLET should be used with caution in elderly patients. Consult your doctor before taking it.

Cabozanib 60mg Tablet-Overdosage:

If you or anyone else accidentally take too much of Cabozanib 60mg TABLET, consult your doctor immediately or visit the nearby hospital.

Cabozanib 60mg Tablet-Habit Forming

Cabozanib 60mg Tablet is not habit-forming. It is a prescription medication that should be taken as directed by your doctor.

SAFETY ADVICE

warnings
alcohol warning   Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Cabozanib 60mg Tablet. Please consult your doctor.

warnings
Pregnancy care   Pregnancy
CONSULT YOUR DOCTOR
Cabozanib 60mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

warnings
   Breastfeeding
UNSAFE
Cabozanib 60mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

warnings
   Driving Caution
UNSAFE
Cabozanib 60mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

warnings
   Kidney Caution
Cabozanib 60mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Cabozanib 60mg Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Cabozanib 60mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.

warnings
   Liver Caution
Cabozanib 60mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Cabozanib 60mg Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Cabozanib 60mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.

baby warning CHILDREN CAUTION
UNSAFE
Cabozanib 60mg Tablet is not recommended for use in children and adolescents below 18 years.

   expert advice

WHAT IF YOU FORGET TO TAKE Cabozanib 60mg TABLET

If you miss a dose of Cabozanib 60mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Patient Experiences and Testimonials

Understanding the real-world impact of Cabozanib 60mg tablets is crucial for patients considering this treatment. Personal testimonials offer invaluable insights that extend beyond clinical data, illustrating the human aspect of living with and managing cancer. Many patients who have been treated with Cabozanib 60mg tablets have shared their stories, highlighting both the benefits and challenges they encountered.

One patient, John S., a 58-year-old with advanced renal cell carcinoma, described his experience: “When I was first diagnosed, the outlook seemed bleak. However, after starting treatment with Cabozanib 60mg tablets, I noticed a significant reduction in tumor size within a few months. The side effects were manageable, and I was able to maintain a relatively normal lifestyle. It gave me hope and the strength to keep fighting.”

Similarly, Maria L., a 45-year-old patient with metastatic thyroid cancer, shared her journey: “Cabozanib 60mg tablets were a game-changer for me. Despite the initial fatigue and occasional nausea, the medication controlled the progression of my cancer. I was able to spend more quality time with my family, which was a blessing. It’s not just about the physical benefits; it’s about the emotional and mental relief that comes from seeing positive results.”

However, not all experiences are entirely positive. Some patients have faced significant challenges. David R., a 62-year-old with hepatocellular carcinoma, noted: “While Cabozanib 60mg tablets did slow down the growth of my tumors, the side effects were tough to handle. I experienced severe diarrhea and high blood pressure, which required additional medications to manage. Despite these challenges, I believe the benefits outweighed the drawbacks, but it’s important to be prepared for potential side effects.”

These testimonials underscore the varied experiences of patients on Cabozanib 60mg tablets. The medication has provided hope and improved quality of life for many, though it comes with its own set of challenges. Understanding these personal stories helps paint a more comprehensive picture of what patients might expect, contributing to more informed decision-making.

Future Research and Developments

As the medical community continues to explore the full potential of Cabozanib 60mg tablets, ongoing research and future developments hold significant promise. Current clinical trials are focused on examining the efficacy of Cabozanib 60mg in treating a wider array of cancers, beyond its established applications. These trials are pivotal in determining how this medication can be optimized for various oncological conditions, potentially offering new hope to patients with different cancer types.

One of the exciting areas of research is the development of new formulations of Cabozanib 60mg tablets. Advances in drug delivery systems and pharmaceutical technology may lead to improved versions of the medication, which could enhance its effectiveness and reduce side effects. Such innovations aim to provide patients with a more convenient and tolerable treatment experience, thereby improving adherence to the prescribed regimen.

In addition to new formulations, scientists are also delving into the molecular mechanisms of Cabozanib 60mg. Understanding the drug’s interaction with cancer cells at a deeper level could unveil novel therapeutic targets and synergistic combinations with other treatments. This knowledge can contribute to more personalized and precise cancer therapies, aligning with the broader trend towards tailored medical approaches.

The integration of Cabozanib 60mg into the broader landscape of cancer treatment is another critical aspect of ongoing research. Studies are investigating how Cabozanib 60mg can be effectively combined with immunotherapies and other targeted treatments to create comprehensive and robust treatment protocols. These combinational strategies aim to enhance overall efficacy and potentially overcome resistance mechanisms that cancers often develop.

Looking ahead, the future prospects for patients undergoing treatment with Cabozanib 60mg tablets appear promising. The continuous advancements in research and development are not only expanding the drug’s applicability but also paving the way for more effective and patient-friendly cancer therapies. As these efforts progress, Cabozanib 60mg is likely to play an increasingly integral role in the fight against cancer, offering renewed hope and improved outcomes for patients globally.

FAQs about Cabozanib 60mg Tablet

Q 1. What is Cabozanib 60mg Tablet used for?

A: Cabozanib 60mg Tablet is primarily used to treat certain types of cancer, such as kidney cancer and thyroid cancer.

Q 2. When is the best time to take Cabozanib 60mg Tablet?

A: It is recommended to take Cabozanib 60mg Tablet at the same time each day, either with or without food, as directed by your healthcare provider.

Q 3. What are the long-term side effects of Cabozanib 60mg Tablet?

A: Some potential long-term side effects of Cabozanib 60mg Tablet may include fatigue, high blood pressure, and changes in liver function. It is important to discuss any concerns with your healthcare provider.

Q 4. Can you provide a review of Cabozanib 60mg Tablet?

A: Reviews of Cabozanib 60mg Tablet may vary based on individual experiences. It is advisable to consult with your healthcare provider for personalized information and guidance.

Q 5. What are the common uses of Cabozanib 60mg Tablet?

A: Apart from treating kidney and thyroid cancer, Cabozanib 60mg Tablet may also be used to manage other types of cancer as prescribed by a healthcare professional.

Q 6. What is the recommended dosage of Cabozanib 60mg Tablet?

A: The recommended dosage of Cabozanib 60mg Tablet varies depending on the type of cancer being treated and individual patient factors. It is crucial to follow the dosage instructions provided by your healthcare provider.

Q 7. Is Cabozanib 60mg Tablet safe to use?

A: Cabozanib 60mg Tablet is generally considered safe when used as prescribed by a healthcare provider. However, like any medication, it may have potential risks and side effects. It is essential to discuss your medical history and any concerns with your healthcare provider before starting treatment.

Q 8. Are there any precautions to be aware of while taking Cabozanib 60mg Tablet?

A: Before taking Cabozanib 60mg Tablet, inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking to ensure safe and effective treatment.

Q 9. How long does it take for Cabozanib 60mg Tablet to show results?

A: The time it takes for Cabozanib 60mg Tablet to show results may vary depending on individual responses and the specific type of cancer being treated. It is important to follow your healthcare provider’s instructions and attend follow-up appointments for monitoring.

Q 10. Can Cabozanib 60mg Tablet be taken with other medications?

A: It is essential to inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting Cabozanib 60mg Tablet to prevent potential interactions. Your healthcare provider will advise you on the safe use of other medications alongside Cabozanib 60mg Tablet.

References:

  1. Ipsen Pharma, Electronic Medicines Compendium (EMC), [Revised on July 2022] [Accessed on 25th April 2023], Cabometyx 20 mg Film-coated Tablets – Summary of Product Characteristics (SmPC) – (emc) (medicines.org.uk)
  2. Exelixis, Inc., [Revised on Oct 2020] [Accessed on 25th April 2023], https://www.cometriq.com/downloads/Cometriq_Full_Prescribing_Information.pdf
  3. Gregory A. Brent and Ronald J. Koenig, Thyroid and Antithyroid Drugs, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 2018, 787-801.
Scroll To Top
Close
Close
Close

My Cart

Shopping cart is empty!

Continue Shopping

Open chat
Need Help?
Welcome to HIVHUB
Hello
Can we help you ?